-
S19 - Scientific symposium sponsored by Eli Lilly - Tirzepatide and the Cardiologist: A New Chapter in Cardiometabolic Risk Management
Done
-
S16 - Scientific symposium sponsored by MSD - Next-Gen Therapies in Cardiology: from Sotatercept to the Future of Lipid Management
Done
-
S26 - Scientific symposium sponsored by Novo Nordisk - Beyond Metabolic Control: Incretin Mimetics as Gamechangers in Cardiometabolic Inflammation and CV Risk
Done
-
S22 - Scientific symposium sponsored by Bayer: Beyonttra: A new chapter in ATTR-CM management
Done
-
S10 - Scientific symposium sponsored by Alnylam - A new chapter in ATTR-CM: what comes next in clinical practice?
Done
-
S13 - Scientific symposium sponsored by BMS - Cardiovascular care and prevention through an economic lens: optimizing oHCM via early search, detection, treatment, and structured care
Done
-
S29 - BWGNICI - Imaging in inflammatory myopericardial syndrome: update from the 2025 Guidelines
Done
-
S2 - Radiation
Done
-
S18 - BWGIC - Filling the gap between treatment guidelines and current practice in Belgium
Done
-
S14 - Nursing - 5 - Artificial Intelligence in Cardiac Nursing: Transforming Care Through Technology
Done
Anne-Catherine Pouleur - UCL Saint Luc, Brussels
11:35–11:40, Welcome and objectives
More information soon
11:40–12:00, Implementation of AI into clinical practice: early detection and prevention of cardiovascular diseases
Louise Vander Heyde is a datascientist working at RADar, the Learning and Innovation Centre of AZ Delta Roeselare under supervision of Prof. Peter De Jaeger.
She works in close collaboration with the Cardiology Department of AZ Delta Roeselare under supervision of Dr. Karl Dujardin.
Louise obtained her master’s degree in Biomedical Engineering from Ghent University in 2023.
Her research focuses on the application of artificial intelligence to electrocardiography, with particular interest in model development, clinical validation, and the safe integration of AI-based tools into cardiac care.
More information soon
12:00–12:20, Closing the Diagnostic Gap in HFpEF: A Structured Dyspnea Clinic Approach
Dr. Jan Verwerft studied medicine at KU Leuven, where he completed his clinical training in cardiology with residencies at OLV Hospital Aalst, University Hospital Leuven, and AZ Delta Roeselare. He later pursued a heart failure fellowship at the Erasmus MC Thoraxcenter.
Since 2006, he has been practicing as a cardiologist at the Heart Center of JESSA Hospital Hasselt, where he focuses on diagnosing and treating heart failure with preserved ejection fraction (HFpEF) in a specialized dyspnea clinic. His main clinical and research interest lies in the integration of exercise echocardiography with cardiopulmonary exercise testing (CPETecho).
He obtained his PhD from Hasselt University in 2025, successfully defending his thesis entitled “Cardiopulmonary exercise testing combined with echocardiography for the evaluation of exercise limitations: unmasking deficits in the oxygen cascade.”
12:20–12:40, Resistant Hypertension Work-Up
Philippe van de Borne is Professor of Cardiology at the Université libre de Bruxelles (HUB-Erasme).
He completed a Fogarty Fellowship at the National Institutes of Health (USA), where he conducted research on autonomic dysfunction in heart failure.
His current work focuses on cardiovascular prevention—including diabetes, hypercholesterolemia, obesity, hypertension, and thrombosis—and on cardiac rehabilitation.
A former President of the Belgian Working Group on Cardiovascular Prevention and Rehabilitation of the Belgian Society of Cardiology, he has authored or co-authored 294 publications (H-index 60), received several international awards, and is actively involved in European and Belgian cardiology and hypertension societies.
